Cite
HARVARD Citation
Bal, C. et al. (n.d.). Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab')2 fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, phase 1 study. Lancet infectious diseases. 15 (3), pp. 285-292. [Online].